These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Pharmacokinetics of 1R-cis 1'R-cis atracurium besylate (51W89) and plasma laudanosine concentrations in health and chronic renal failure. Eastwood NB; Boyd AH; Parker CJ; Hunter JM Br J Anaesth; 1995 Oct; 75(4):431-5. PubMed ID: 7488483 [TBL] [Abstract][Full Text] [Related]
3. A comparison of the infusion pharmacokinetics and pharmacodynamics of cisatracurium, the 1R-cis 1'R-cis isomer of atracurium, with atracurium besylate in healthy patients. Smith CE; van Miert MM; Parker CJ; Hunter JM Anaesthesia; 1997 Sep; 52(9):833-41. PubMed ID: 9349062 [TBL] [Abstract][Full Text] [Related]
4. Pharmacodynamics of the 1R cis-1'R cis isomer of atracurium (51W89) in health and chronic renal failure. Boyd AH; Eastwood NB; Parker CJ; Hunter JM Br J Anaesth; 1995 Apr; 74(4):400-4. PubMed ID: 7734258 [TBL] [Abstract][Full Text] [Related]
5. Pharmacokinetics of atracurium and laudanosine in the elderly. Kent AP; Parker CJ; Hunter JM Br J Anaesth; 1989 Dec; 63(6):661-6. PubMed ID: 2611066 [TBL] [Abstract][Full Text] [Related]
6. Atracurium and laudanosine pharmacokinetics in acute renal failure. Hunter JM Intensive Care Med; 1993; 19 Suppl 2():S91-3. PubMed ID: 8106685 [No Abstract] [Full Text] [Related]
7. Comparison of the pharmacodynamics and pharmacokinetics of an infusion of cis-atracurium (51W89) or atracurium in critically ill patients undergoing mechanical ventilation in an intensive therapy unit. Boyd AH; Eastwood NB; Parker CJ; Hunter JM Br J Anaesth; 1996 Mar; 76(3):382-8. PubMed ID: 8785138 [TBL] [Abstract][Full Text] [Related]
8. Effect of age on cis-atracurium besylate pharmacokinetics following a single 1 mg kg Aguilar A; Andaluz A; Moll X; Cristòfol C; García F Vet Anaesth Analg; 2019 Sep; 46(5):643-651. PubMed ID: 31155378 [TBL] [Abstract][Full Text] [Related]
9. Pharmacokinetics and pharmacodynamics of the benzylisoquinolinium muscle relaxants. Hull CJ Acta Anaesthesiol Scand Suppl; 1995; 106():13-7. PubMed ID: 8533537 [TBL] [Abstract][Full Text] [Related]
10. High-performance liquid chromatographic method for the determination of atracurium and laudanosine in human plasma. Application to pharmacokinetics. Farenc C; Audran M; Lefrant JY; Mazerm I; Bressolle F J Chromatogr B Biomed Sci Appl; 1999 Mar; 724(1):117-26. PubMed ID: 10202964 [TBL] [Abstract][Full Text] [Related]
11. Pharmacokinetics and pharmacodynamics of cisatracurium in patients with end-stage liver disease undergoing liver transplantation. De Wolf AM; Freeman JA; Scott VL; Tullock W; Smith DA; Kisor DF; Kerls S; Cook DR Br J Anaesth; 1996 May; 76(5):624-8. PubMed ID: 8688259 [TBL] [Abstract][Full Text] [Related]
12. A pharmacokinetic-pharmacodynamic model for a muscle relaxant: atracurium. Nigrovic V; Gaspari J; Banoub M Eur J Clin Pharmacol; 1996; 49(4):325-32. PubMed ID: 8857080 [TBL] [Abstract][Full Text] [Related]
13. The pharmacokinetics and pharmacodynamics of atracurium in patients with and without renal failure. Fahey MR; Rupp SM; Fisher DM; Miller RD; Sharma M; Canfell C; Castagnoli K; Hennis PJ Anesthesiology; 1984 Dec; 61(6):699-702. PubMed ID: 6239574 [TBL] [Abstract][Full Text] [Related]
14. Pharmacokinetics of atracurium and laudanosine in patients with hepatic cirrhosis. Parker CJ; Hunter JM Br J Anaesth; 1989 Feb; 62(2):177-83. PubMed ID: 2923767 [TBL] [Abstract][Full Text] [Related]
15. Clinical pharmacokinetics of the newer neuromuscular blocking drugs. Atherton DP; Hunter JM Clin Pharmacokinet; 1999 Mar; 36(3):169-89. PubMed ID: 10223167 [TBL] [Abstract][Full Text] [Related]
16. Laudanosine and atracurium concentrations in a patient receiving long-term atracurium infusion. Grigore AM; Brusco L; Kuroda M; Koorn R Crit Care Med; 1998 Jan; 26(1):180-3. PubMed ID: 9428564 [TBL] [Abstract][Full Text] [Related]